IκB kinase β (IKBKB) mutations in lymphomas that constitutively activate canonical nuclear factor κB (NFκB) signaling

J Biol Chem. 2014 Sep 26;289(39):26960-26972. doi: 10.1074/jbc.M114.598763. Epub 2014 Aug 8.

Abstract

Somatic mutations altering lysine 171 of the IKBKB gene that encodes (IKKβ), the critical activating kinase in canonical (NFκB) signaling, have been described in splenic marginal zone lymphomas and multiple myeloma. Lysine 171 forms part of a cationic pocket that interacts with the activation loop phosphate in the activated wild type kinase. We show here that K171E IKKβ and K171T IKKβ represent kinases that are constitutively active even in the absence of activation loop phosphorylation. Predictive modeling and biochemical studies establish why mutations in a positively charged residue in the cationic pocket of an activation loop phosphorylation-dependent kinase result in constitutive activation. Transcription activator-like effector nuclease-based knock-in mutagenesis provides evidence from a B lymphoid context that K171E IKKβ contributes to lymphomagenesis.

Keywords: I Kappa B Kinase Beta; Lymphoma; Molecular Modeling; Mutant; NF-kappa B (NF-κB); Protein Kinase; Serine/Threonine Protein Kinase; Signaling; Transcription Activator-like Effector Nuclease (TALEN).

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Amino Acid Substitution
  • HeLa Cells
  • Humans
  • I-kappa B Kinase* / immunology
  • I-kappa B Kinase* / metabolism
  • Lymphoma* / genetics
  • Lymphoma* / metabolism
  • Mutation, Missense*
  • NF-kappa B* / genetics
  • NF-kappa B* / metabolism
  • Neoplasm Proteins* / genetics
  • Neoplasm Proteins* / metabolism
  • Phosphorylation / genetics
  • Signal Transduction / genetics*

Substances

  • NF-kappa B
  • Neoplasm Proteins
  • I-kappa B Kinase
  • IKBKB protein, human